WuXi AppTec has added three key senior professionals. Dr. Brian J. Xu has joined the company as vice president of toxicology and head of the safety evaluation center at Suzhou, reporting to Dr. Ge Li, chairman and chief executive officer. Dr. Xu is an American Board Certified Toxicologist (DABT) and previously held positions at Merck, Roche, Schering-Plough and Enzon.

Dr. Yang-Dar Yuan joined the company as vice president of operation and head of pathology of the Safety Evaluation Center, reporting to Dr. Brian Xu. Dr. Yuan is a member of American College of Veterinary Pathologists (ACVP), a member of the American College of Laboratory Animal Medicine and an American Board Certified Toxicologist (DABT). He has more than 30 years of experience in preclinical safety assessment and drug development. Dr. Yuan previously held positions at Upjohn, Pfizer, Allergan and Vitae Pharmaceutical.

Mr. Robert Coldreck has joined the company as head of GLP (Good Laboratory Practice) QA (Quality Assurance). Mr. Coldreck most recently served as director of laboratory and preclinical quality assurance-North America and Asia for at Novartis. He has more than 30 years of experience in GLP quality assurance.

“I am delighted to welcome Brian, Yang-Dar and Bob to our management team to lead our preclinical services,” said Dr. Li. “With their rich experience and knowledge in GLP preclinical studies and their strong leadership in respective fields, WuXi continues to build a world-class preclinical service platform to serve our customers’ demands.”